The HDL Particle Protection Study

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

May 14, 2017

Study Completion Date

May 14, 2017

Conditions
Dyslipidemia in Patients With Diabetes Mellitus
Interventions
DRUG

atovastatin 10 mg/day

patients will receive 10 mg of atorvastatin daily for 8 weeks, then wash out for 6 weeks then cross over to atorvastatin 80 mg daily for 8 weeks

DRUG

Atorvastatin 80 mg/day

patients will receive 80 mg of atorvastatin daily for 8 weeks, then wash out for 6 weeks then cross over to atorvastatin 10 mg daily for 8 weeks

Trial Locations (1)

Beirut

Hotel Dieu de France Hospital, Beirut

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Nouvelle Société Française d'Athérosclérose

UNKNOWN

collaborator

Pfizer

INDUSTRY

lead

Hotel Dieu de France Hospital

OTHER

NCT02125682 - The HDL Particle Protection Study | Biotech Hunter | Biotech Hunter